<p>Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice! </p>

Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice!

<p>Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice!&nbsp;</p>

Episode 2: We Don't Talk About Rylaze

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!

Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Medicine

Health & Fitness

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Share Episode 2: We Don't Talk About Rylaze

Sign up to save your podcasts

Episode 2: We Don't Talk About Rylaze

Episode 2: We Don't Talk About Rylaze

More shows like WolverHeme Happy Hour

Fresh Air

The NPR Politics Podcast

Pod Save America

The Daily

Up First from NPR

OncoPharm

Today, Explained

Interesting Times with Ross Douthat

Blood Podcast

ASTCT Talks

The Ezra Klein Show

The Weekly Show with Jon Stewart

Blood Cancer Talks

Two Onc Docs

The Headlines